Results 51 to 60 of about 5,130,717 (259)
ABSTRACT Aim Bile acids accumulation in hepatocytes causes liver damage and contributes to the development of hepatocellular carcinoma. However, the association between serum bile acid levels and postoperative intrahepatic recurrence in hepatocellular carcinoma remains unclear.
Tomoaki Bekki +9 more
wiley +1 more source
Experience of Using Ursodeoxycholic Acid in Children with Organic Diseases of the Liver
The mechanisms of ursodeoxycholic acid effects on the human body, the findings of clinical studies and observations on the use of ursodeoxycholic acid preparation for the treatment of children with organic diseases of the liver were considered.
Ye.N. Babadzhanian
doaj +1 more source
Ursodeoxycholic acid augmentation in treatment-refractory schizophrenia: a case report
Background Treatment-resistance is recognized as a significant dilemma in schizophrenia, which has been reported to involve approximately one-third of patients with schizophrenia.
Mohsen Khosravi
doaj +1 more source
ABSTRACT Biallelic pathogenic variants in AKR1D1 cause Δ4‐3‐oxosteroid 5β‐reductase deficiency, disrupt bile acid synthesis, and result in Congenital Bile Acid Synthesis defect type 2 (CBAS2). CBAS2 presents in infancy with cholestasis, coagulopathy, and failure to thrive.
Jade Hudson +3 more
wiley +1 more source
In Xanthium strumarium toxicity, mitochondrial dysfunction resulting from the opening of mitochondrial pores is identified as the primary mechanism responsible for liver and kidney damage.
Zeliha Keskin Alkaç +4 more
doaj +1 more source
Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development
It has been previously reported that ursodeoxycholic acid (UDCA), a therapeutic bile acid, reduced risk for advanced colorectal adenoma in men but not women.
Talima R. Pearson +13 more
semanticscholar +1 more source
ABSTRACT Cytosolic phosphoenoylpyruvate carboxykinase (PEPCK‐C) is an essential, rate‐limiting enzyme in the gluconeogenesis pathway. PEPCK‐C deficiency presents with hypoglycaemia, hyperlactataemia and hepatopathy, and was first reported in association with bi‐allelic PCK1 variants in 2014.
Isaac Bernhardt +9 more
wiley +1 more source
Optimization of the Treatment Protocol in Children with Gastroesophageal Reflux Disease
The article deals with the substantiation and assessment of the effectiveness of the inclusion of ursodeoxycholic acid preparation Ukrliv suspension in the treatment protocol of children with gastroesophageal reflux disease.
T.O. Kriuchko +3 more
doaj +1 more source
Aims Atypical colitis (presenting reverse gradient colitis, backwash ileitis or rectal sparing) is associated with primary sclerosing cholangitis–ulcerative colitis (PSC). Oral vancomycin has been used to manage paediatric atypical colitis with/without confirmed PSC. Different preparations had shown different efficacy.
Laura Räisänen +4 more
wiley +1 more source
The Role of Ursodeoxycholic Acid in Acute Viral Hepatitis: an Evidence-based Case Report
Aim: to review the role of ursodeoxycholic acid in acute viral hepatitis. Methods: following literature searching according to the clinical question on Pubmed and Cochrane Library.
Indra Wijaya
doaj +4 more sources

